About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
266
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05650229Lead Sponsor
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
PHASE2Recruiting
180 participants
Started: Dec 13, 2022 · Completed: Nov 30, 2027
NCT04643249Lead Sponsor
Drug-drug Interaction Study of KL1333 in Healthy Subjects
PHASE1Completed
14 participants
Started: Nov 10, 2020 · Completed: Dec 17, 2020
NCT03888716Lead Sponsor
A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease
PHASE1Completed
72 participants
Started: Mar 18, 2019 · Completed: Mar 16, 2021
Locations (1)
Headquarters
Lund, Sweden
Map
Loading map...